Lushang Freda Pharmaceutical Co., Ltd. Class A (600223.SS) SHH
Currency In CNY
AD
- General
- Statistics
- Historical Data
- Profile
- Financials
Valuation
| Market Cap | 7.48B |
| Enterprise Value | 4.74B |
| P/E Ratio | 31.92 |
| PEG Ratio | -1.05 |
| Price/Sales Ratio | 1.45 |
| Price/Book Ratio | 1.31 |
| Enterprise/Revenue | 0.72 |
| Enterprise/EBITDA | 8.85 |
Fiscal Year
| Fiscal Year | December 31, 2025 |
| Most Recent Quarter | March 31, 2026 |
Profitability
| Profit Margin | 0.05 |
| Operating Margin | 0.05 |
AD
Management Effectiveness
| Return On Assets | 0.03 |
| Return On Equity | 0.04 |
Income Statement
| Revenue | 3.63B |
| Revenue/Share | 3.46 |
| Gross Profit | 1.85B |
| EBITDA | 414.07M |
| Net Income | 187.75M |
| Diluted EPS | 0.18 |
Balance Sheet
| Total Cash | 2.87B |
| Total Cash/Share | 2.7 |
| Total Debt | 170.81M |
| Total Debt/Equity | 0.04 |
| Current Ratio | 4.61 |
| Book Value Per Share | 4.69 |
Price History
| 52-Week Change | -35.46 |
| 52-Week High | 8.78 |
| 52-Week Low | 5.04 |
| Moving Average 50 Days | 6.29 |
| Moving Average 200 Days | 7.18 |
Statistics
| Average Volume | 7.04M |
| Shares Outstanding | 1.02B |
| % Held by Institutions | N/A |
Dividend And Splits
| Trailing Annual Dividend Rate | 0.11 |
| Trailing Annual Dividend Yield | 2.09 |
| Payout Ratio | 0.01 |
| Last Split Factor | 5:4 |
| Last Split Date | February 20, 2006 |
AD
